Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Amerigo Scientific's New Lab Offering: S-Silver SERS Substrates

    Dec 8, 2023, 07:44 AM by
    Full story
  • For Rare Disease, What’s Missed by Genome Sequencing Still Matters

    Dec 8, 2023, 01:00 AM by User Not Found
    Bio-IT World | For almost two decades, members of the life science community bemoaned something that most outsiders never realized: that the “finished” human genome assembly had never actually been finished. Now, thanks to remarkable efforts from the Telomere-to-Telomere (T2T) consortium, we finally have a complete human reference genome.
    Full story
  • CellNetix Selects Proscia To Deliver New Standard Of Excellence In Pathology

    Dec 7, 2023, 08:06 AM by
    Modernizing the 150-year-old microscope-based practice with digital innovation
    Full story
  • InSysBio to release public beta of fIVE Calculator

    Dec 7, 2023, 08:06 AM by
    Now InSysBio presents public beta release of fIVE Calculator which is a web application designed to automatically calculate kinetic parameters from in vitro experiments for modeling of biosystems.
    Full story
  • Abzena Partners with ProteoNic to Offer Enhanced CHO Cell Line Platform for Complex Biologics

    Dec 7, 2023, 08:06 AM by
    Full story
  • Optibrium’s Quantum Mechanics and Machine Learning Methods Predict Routes of Drug Metabolism

    Dec 7, 2023, 08:06 AM by
    Full story
  • Revolutionary Danish Cancer App Set for Nationwide Launch: A Milestone in Digital Healthcare

    Dec 6, 2023, 09:21 AM by
    Full story
  • Recipharm announces collaboration with Oz-UK to accelerate the development of low global warming potential pMDIs utilising HFA-152a propellant

    Dec 6, 2023, 09:21 AM by
    Hi, I hope you are well. Please see below news from Recipharm on its collaboration with CRO, Oz-UK to accelerate the development of low global warming pressurised Metered Dose Inhalers (pMDIs). It has also announced the appointment of Simon Gardner, formerly of HFA-152a propellant supplier, Koura to support customers in their transition to greener propellants. Kind regards Char
    Full story
  • The Last Mile In Preventing A Deadly Hospital Infection

    Dec 6, 2023, 01:00 AM by User Not Found
    Bio-IT World | The “power of the team approach” was on full display for a study designed to understand the contribution of asymptomatic carriers to the spread of Clostridioides difficile in hospitals.
    Full story
  • LIQUID STABLE & NIST TRACEABLE CLINICAL REFERENCE MATERIALS FOR MAGNESIUM SERUM & URINE TESTING AVAILABLE FROM VERICHEM

    Dec 5, 2023, 08:05 AM by
    VERICHEM now offers calibration verification materials for the testing of both urine and serum Magnesium assays.
    Full story
  • XponentL Data Announces the Launch of a GenAI Lab within our Data and AI Center of Excellence in Kosovo

    Dec 5, 2023, 08:05 AM by
    XponentL Data has announced the launch of its GenAI Lab within its Kosovo Data and AI Center of Excellence. This lab aims to accelerate innovation in Data and AI by enabling rapid testing, validation, and deployment of GenAI solutions in various sectors like healthcare, finance, and energy. Led by Elkida Bazaj, a leading AI engineer, the lab will collaborate with partners like AWS, Databricks, and Snowflake to develop practical AI applications and a use case library to enhance clients' understanding and application of GenAI technologies. The GenAI Lab will also focus on improving data quality in different business domains, starting with pharmaceutical clinical trials, leveraging large language models and generative AI.
    Full story
  • DoseMe Adds Cefepime to Its Model-informed Precision Dosing Platform

    Dec 5, 2023, 08:05 AM by
    DoseMe today announced the availability of its Cefepime model. This model will offer pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for Cefepime in critically ill patients, including those with unstable renal function, a common challenge faced by clinicians taking care of these complex patients.
    Full story
  • Bringing Your Research to the Market With Tom Miller

    Dec 5, 2023, 01:00 AM by User Not Found
    Bio-IT World | When Tom Miller was a professor at the California Institute of Technology, he built a research program centered around developing AI and data-driven algorithms to help solve chemistry and biological challenges with various research focuses. These scientific innovations led to increasingly translational capabilities, and Miller realized he had to bring his research to a bigger platform.
    Full story
  • WCG Revolutionizes Ethical Review Process with IRB+ Service, Achieving Unprecedented Efficiency Gains

    Dec 1, 2023, 09:04 AM by
    WCG's IRB+ service has been pressure tested on 90+ studies, ensuring that it maintains the integrity and quality of board reviews while accelerating operational processing, allowing for faster site activation and study start-up.
    Full story
  • Ransomware Attacks Up 81% Year-on-Year in October

    Dec 1, 2023, 09:04 AM by
    A new research report issued today by NCC Group – a global cyber security and software escrow business with nearly 2,000 employees in 12 countries and over 14,000 clients – finds that ransomware attacks increased 81% between October last year and this. The report explores ransomware trends for October through monitoring data leak sites used by each ransomware group and scraping victim details as they are released. It then classifies the victims by sector to derive additional insights and compares the findings to previous months
    Full story
  • Lactocore and Ingredia Collaborate on Innovative Functional Food Ingredients Relieving Mood Disorders in Humans and Animals

    Dec 1, 2023, 09:04 AM by
    Biotech startup Lactocore Group has initiated a research partnership with Ingredia SA, a French dairy company specializing in developing and manufacturing innovative food and bioactive ingredients.
    Full story
  • Increased Comfort and Greater Insight with EnFocus OCT Optimized Design

    Dec 1, 2023, 09:04 AM by
    Next-generation Integrated Intraoperative OCT for Proveo 8 to be Unveiled at the FLORetina ICOOR Meeting 2023
    Full story
  • Copyright Clearance Center Wins 2023 European Best of Show Award for Scientific Article Exploration Tool

    Nov 30, 2023, 09:45 AM by User Not Found
    Bio-IT World | The Bio-IT World community has chosen the 2023 Best of Show Awards Europe winner. The more than 300 event attendees in London were invited to vote for their favorite solutions, and they chose to honor RightFind XML from Copyright Clearance Center (CCC) as the 2023 honoree.
    Full story
  • Ardena's new Aseptic Fill-Finish Plant in Ghent receives GMP license

    Nov 30, 2023, 09:12 AM by
    Full story
  • Sygnature Discovery appoints new industry leaders to their board of directors

    Nov 30, 2023, 09:12 AM by
    I'm getting in touch with the latest news from Sygnature Discovery, a world-leading contract research organization. The company has recently appointed two industry leaders, Vanessa Malier and Martin LeBlanc, to their board of directors, reinforcing its commitment to innovation and strategic leadership. With decades of experience and a wealth of expertise in their respective fields, both Martin and Vanessa bring unique and valuable perspectives to Sygnature Discovery's board. Further details can be found in the press release below. I have also attached headshots of both Vanessa and Martin to this email. Please let me know if you have any questions or if you require any further information. Many thanks, Charlotte
    Full story
  • «
  • 61 (current)
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy